CME Group CEO Terrence Duffy sells 25,000 company shares

CME Group Inc. reported that its Chairman and CEO Terrence A. Duffy, who is also a director, sold 25,000 shares of Class A common stock on December 11, 2025.

Rhea-AI Filing Summary

CME Group Inc. reported that its Chairman and CEO Terrence A. Duffy, who is also a director, sold 25,000 shares of Class A common stock on December 11, 2025.

The sale was executed in two trades: 13,809 shares at prices ranging from $268.66 to $269.66 per share and 11,911 shares at prices ranging from $269.68 to $270.51 per share, with prices within each $1 range aggregated and reported on a weighted-average basis. After these transactions, Duffy directly beneficially owned 65,804 Class A shares.

Insider Trade Summary

Net Seller: 25,000 shares

Net Sell 2 txns

Insider DUFFY TERRENCE A

Role Chairman and CEO

Sold 25,000 shs ($6.74M)

Type	Security	Shares	Price	Value
Sale	Common Stock Class A	13,089	$269.10	$3.52M
Sale	Common Stock Class A	11,911	$270.05	$3.22M

Holdings After Transaction: Common Stock Class A — 65,804 shares (Direct)

Footnotes (1)

1. F1. On December 11, 2025, Mr. Duffy sold an aggregate of 25,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $268.66 to $269.66 for 13,809 shares and $269.68 to $270.51 for 11,911 shares. The Company maintains a record of the transaction and copies will be provided upon request.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CME report for Terrence Duffy?

Terrence A. Duffy, Chairman and CEO of CME Group Inc., sold a total of 25,000 shares of Class A common stock on December 11, 2025.

At what prices were the CME Group Class A shares sold?

The filing reports two price ranges: $268.66 to $269.66 for 13,809 shares and $269.68 to $270.51 for 11,911 shares, based on weighted-average prices within each $1 range.

How many CME Group shares does Terrence Duffy own after the sale?

Following the reported transactions, Terrence Duffy directly beneficially owned 65,804 shares of CME Group Class A common stock.

What is Terrence Duffys role at CME Group?

Terrence A. Duffy is identified as a Director and an Officer, serving as Chairman and CEO of CME Group Inc.

Was this CME Group insider filing made by more than one reporting person?

No. The form indicates that it is a Form filed by One Reporting Person, covering only Terrence A. Duffy.

What type of security did Terrence Duffy sell in this CME transaction?

The transaction involved sales of Common Stock Class A of CME Group Inc., reported as non-derivative securities in Table I.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/15/2025 - 03:05 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DUFFY TERRENCE A

(Last) (First) (Middle)

20 S. WACKER DRIVE

(Street)

CHICAGO IL 60606

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CME GROUP INC. [ CME ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman and CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock Class A	12/11/2025		S		13,089	D	$269.1(1)	77,715	D
Common Stock Class A	12/11/2025		S		11,911	D	$270.05(1)	65,804	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On December 11, 2025, Mr. Duffy sold an aggregate of 25,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $268.66 to $269.66 for 13,809 shares and $269.68 to $270.51 for 11,911 shares. The Company maintains a record of the transaction and copies will be provided upon request.

Remarks:

	By: Margaret Austin Wright For: Terrence A. Duffy	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.